A postharvest treatment using sodium nitroprusside (SNP), a nitric oxide donor, to delay senescence in fresh fruits and vegetables. SNP suppresses oxidative stress, enhances antioxidant capacity, and reduces chlorophyll degradation, offering a promising approach to extend produce shelf-life and reduce postharvest losses.
This research focuses on extending the shelf-life of fresh fruits and vegetables through the application of nitric oxide (NO), specifically using sodium nitroprusside (SNP) as an NO donor. Postharvest losses of fresh produce represent a significant economic and sustainability challenge. The proposed approach leverages the biological role of NO in mediating plant defensive responses to stress, including suppression of hydrogen peroxide accumulation and lipid peroxidation, both of which contribute to senescence. By enhancing antioxidant capacity and maintaining cellular redox homeostasis, SNP treatment has the potential to delay ripening, preserve visual quality, and extend the marketable life of fresh produce.
Mechanism of action:
Observed effects in prior studies:
Planned validation activities:
This research is at an early-to-mid stage of development. Prior studies from other groups have demonstrated proof-of-concept for SNP application in delaying senescence in blueberries, bananas, and broccoli. The University of Florida team plans to extend this work by systematically testing SNP concentrations on additional commodities, measuring physiological and biochemical markers, and investigating the underlying molecular mechanisms through gene expression analysis. Further validation is needed to optimize treatment protocols, determine efficacy across different produce types, and establish commercial readiness before deployment in postharvest handling operations.
The University of Florida is a comprehensive public research university with a broad academic and research portfolio and a statewide presence. Industry collaborates through co-located labs and shared core facilities and through an integrated academic health system that accelerates clinical translation. A statewide extension network and multiple research and education sites connect companies with field-scale testing and rapid deployment, while incubators and an adjacent innovation district provide pathways from lab to market. Research is supported by competitive funding from major federal agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office supports IP, licensing, and startup formation.